Journal of Mushroom (한국버섯학회지)

The Korean Society of Mushroom Science (한국버섯학회)
권호 표지
DOI QR코드

DOI QR Code

A comprehensive review of the therapeutic effects of Hericium erinaceus in neurodegenerative disease

  • Kim, Young Ock (Herbal Crop Utilization Research Team, Department of Medicinal Crop Research, National Institute of Horticultural & Herbal Science, Rural Development Administration) ;
  • Lee, Sang Won (Herbal Crop Utilization Research Team, Department of Medicinal Crop Research, National Institute of Horticultural & Herbal Science, Rural Development Administration) ;
  • Kim, Jin Seong (Herbal Crop Utilization Research Team, Department of Medicinal Crop Research, National Institute of Horticultural & Herbal Science, Rural Development Administration)
  • Received : 2014.06.18
  • Accepted : 2014.06.25
  • Published : 2014.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Mushrooms are considered not only as food but also for source of physiologically beneficial medicines. The culinary-medicinal mushrooms may important role in the prevention of age-associated neurological dysfunctions, including Alzheimer's and Parkinson's diseases. Hericium erinaceus (H. erinaceus), is edible mushrooms, is a parasitic fungus that grows hanging off of logs and trees and well established candidate for brain and nerve health. H. erinaceus contains high amounts of antioxidants, beta-glucan, polysaccharides and a potent catalyst for brain tissue regeneration and helps to improve memory and cognitive functions. Its fruiting bodies and the fungal mycelia exhibit various pharmacological activities, including the enhancement of the immune system, antitumor, hypoglycemic and anti-aging properties. H. erinaceus stimulates the synthesis of Nerve Growth Factor (NGF) which is the primary protein nutrient responsible for enhancing and repairing neurological disorders. Especially hericenones and erinacines isolated from its fruitin body stimulate NGF, synthesis. This fungus is also utilized to regulate blood levels of glucose, triglycerides and cholesterol. H. erinaceus can be considered as useful therapeutic agents in the management and/or treatment of neurodegeneration diseases. However, this review focuses on in vitro, in vivo and clinical trials for neurodegerative disease.

Keywords

References

  1. Capsoni S, Giannotta S, Cattaneo A. 2002. Nerve growth factor and galatamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice. Proc Natl Acad Sci USA. 99:12423-12437.
  2. Chang ST, Buswell JA. 2008. Development of the world mushroom industry: Applied mushroom biology and international mushroom organizations. Int J Med Mushrooms. 10:195-208. https://doi.org/10.1615/IntJMedMushr.v10.i3.10
  3. Kawagishi H, Ando M, Mizuno T. 1990. Hericenone A and B as cytotoxic principles from the mushroom Hericium erinaceum. Tetrahedron Lett. 31:373-376. https://doi.org/10.1016/S0040-4039(00)94558-1
  4. Kawagishi H, Ando M, Sakamoto H. 1991. Hericenone C, D and E, stimulators of nerve growth factor (NGF) synthesis, from the mushroom Hericium erinaceum. Tetrahedron Lett. 32:4561-4564. https://doi.org/10.1016/0040-4039(91)80039-9
  5. Kawagishi H, Ando M, Shinba K. 1993. Chromans, hericenone F, G and H from the mushroom Hericium erinaceum. Phytochemistry. 32:175-178.
  6. Kawagishi H, Shimada A, Shirai R. 1994. Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett. 35:1569-1572. https://doi.org/10.1016/S0040-4039(00)76760-8
  7. Kenmoku H, Shimai T, Toyomasu T, Kato N, Sassa T, Erinacine Q. 2002. A new erinacine from Hericium erinaceum, and its biosynthetic route to erinacine C in the basidiomycete. Biosci Biotechnol Biochem. 66:571-575. https://doi.org/10.1271/bbb.66.571
  8. Mattson MP. 1997. Neuroprotective signal transduction: relevance to stroke. Neurosci Biobehav Rev. 21:193-206. https://doi.org/10.1016/S0149-7634(96)00010-3
  9. Mori K, Obara Y, Hirota M, Azumi Y, Kinugasa S, Inatomi S, Nakahata N. 2008. Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biol Pharm Bull. 31:1727-1732. https://doi.org/10.1248/bpb.31.1727
  10. Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. 2009. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 23:367-372. https://doi.org/10.1002/ptr.2634
  11. Nagano M, Shimizu K, Kondo R, Hayashi C, Sato D, Kitagawa K, Ohnuki K. 2010. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomed Res. 31:231-237. https://doi.org/10.2220/biomedres.31.231
  12. Obara Y, Nakahata N. 2002. The signaling pathway of neurotropic factor. Drug News and Perspect. 15:290-298. https://doi.org/10.1358/dnp.2002.15.5.840042
  13. Park YS, Lee HS, Won MH, Lee JH, Lee SY, Lee HY. 2002. Effect of an exo-polysaccharide from the culture broth of hericium erinaceus on enhancement of growth and differentiation of rat adrenal nerve cells. Cytotechnology. 39:155-162. https://doi.org/10.1023/A:1023963509393
  14. Saito T, Aoki F, Hirai H, Inagaki T, Matsunaga Y, Sakakibara T, Sakemi S, Suzuki Y, Watanabe S, Suga O, Sujaku T, Smogowicz AA, Truesdell SJ, Wong JW, Nagahisa A, Kojima Y, Kojima N. 1998. Erinacine E as a kappa opioid receptor agonist and its new analogs from a basidiomycete, Hericium ramosum. J Antibiot (Tokyo). 51:983-990. https://doi.org/10.7164/antibiotics.51.983
  15. Stamets P. 2005. Notes on nutritional properties of culinary-medicinal mushrooms. Int J Med Mushrooms. 7:109-116.
  16. Stein C, Millan M J, Shippenberg T S, Peter K, Herz A. 1989. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. Pharmacol Exp Ther. 248:1269-1275.
  17. Tuszynski MH, U HS, Amaral DG, Gage FH. 1990. Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci. 10:3604-36014.
  18. Watanabe H, Takano M, Umino A, Ito T, Ishikawa H, and Nakada M. 2007. Enantioselective total synthesis of (-)-erinacine B. Org Lett. 18:359-362.
  19. Wong KH, Sabaratnam V, and Abdullah N. 2007. Activity of aqueous extracts of Lion's Mane Mushroom Hericium erinaceus (Bull.: Fr.) Pers. (Aphyllophoromycetideae) on the neural cell line NG108-15. Int J Med Mushrooms. 9:57-65. https://doi.org/10.1615/IntJMedMushr.v9.i1.70
  20. Yamada K, Nitta A, Hasegawa T, Fuji K, Hiramatsu M, Kameyama T, Furukawa Y, Hayashi K, Nabeshima T. 1997. Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease. Behav Brain Res. 83:117-122. https://doi.org/10.1016/S0166-4328(97)86054-8
  21. Yang BK, Park JB, Song CH. 2003. Hypolipidemic effect of an Exo-biopolymer produced from a submerged mycelial culture of Hericium erinaceus. Biosci Biotechnol Biochem. 67:1292-1298. https://doi.org/10.1271/bbb.67.1292